Abbott (ABT) projects full-year 2025 organic sales growth to be in the range of 7.5%-8.5%. FY25 revenue consensus $44.97B.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, January 21 – January 24, 2025
- Abbott Laboratories (ABT) Q4 Earnings Cheat Sheet
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
- Abbott price target lowered to $135 from $138 at Bernstein